Innovation Focus Leaps by Bayer is heavily invested in disruptive technologies within the life sciences, particularly in health and agriculture, presenting opportunities to provide advanced data integration, analytics, and AI solutions to support their innovative R&D efforts.
Sustainability Alignment The company's strategic commitment to the UN Sustainable Development Goals and the Paris Agreement indicates a focus on eco-friendly and climate-resilient solutions, creating potential for sustainable technology and environmental impact tools.
Recent Partnerships Collaborations with agricultural and infrastructural leaders such as Brazander and Mobility Mojo suggest a demand for advanced agritech, smart infrastructure, and accessibility technology that could enhance their research and operational initiatives.
Technological Ecosystem Utilizing a diverse tech stack, including AI, data analytics, and cloud tools, positions Leaps by Bayer as a potential client or partner for integrating advanced software solutions and enhancing their data-driven innovation processes.
Growth Potential With a revenue range of $1M to $10M and a strategic focus on breakthrough innovations, there are significant opportunities to collaborate on precision agriculture, biotech, and health sciences projects that align with their high-impact investment model.
$500M$1B
$10M$25M
$1M$10M
$500M$1B
$500M$1B
$1M$10MLeaps by Bayer uses 8 technology products and services including Dataiku, Vistex, D2L Brightspace, and more. Explore Leaps by Bayer's tech stack below.
| Leaps by Bayer Email Formats | Percentage |
| First.Last@bayer.com | 93% |
| F-Last@bayer.com | 3% |
| First.Middle@bayer.com | 1% |
| FirstLast@bayer.com | 1% |
| First.MiddleLast@bayer.com | 1% |
| LF@bayer.com | 1% |
Research ServicesBerlin, Germany11-50 Employees
Leaps by Bayer is the strategic investment unit of Bayer AG, backing teams pursuing paradigm-shifting innovations in the life sciences. We make significant, sustained investments in disruptive technologies in health and agriculture, targeting breakthroughs that could drive significant human and financial impact. Leaps aims to address ten huge challenges in these fields. Some call them impossible. We call them “leaps.”
Company Overview
Funding & FinancialsLeaps by Bayer's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsLeaps by Bayer's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com